BlackRock’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-187,700
Closed -$13.9M 5520
2023
Q1
$13.9M Sell
187,700
-661,100
-78% -$55.4M ﹤0.01% 3149
2022
Q4
$79.1M Buy
+848,800
New +$81.9M ﹤0.01% 2166
2020
Q2
Sell
-426,700
Closed -$25.3M 5023
2020
Q1
$25.3M Buy
+426,700
New +$28.5M ﹤0.01% 2481
2019
Q3
Sell
-400,000
Closed -$21.8M 4987
2019
Q2
$21.8M Buy
+400,000
New +$21.5M ﹤0.01% 2793

Other funds holding CVS

BlackRock's CVS Position: Q1 2026 in Review

BlackRock increased its CVS Health (CVS) stake by 4.1% in Q1 2026, buying an estimated $379M and bringing the position to 125,919,853 shares worth $9.04B. The position accounts for 0.16% of the portfolio, ranked #111.

BlackRock first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.65B in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • BlackRock held 125,919,853 shares of CVS Health worth $9.04B as of Q1 2026.
  • BlackRock bought 4,925,379 CVS Health shares in Q1 2026, an estimated $379M.
  • CVS Health made up 0.16% of BlackRock's portfolio in Q1 2026, its #111 holding.
  • BlackRock first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • BlackRock's CVS Health position peaked at $9.65B in Q4 2021.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.